October 5, 2026
CCPA Submits Comments to Senate Finance Committee on Health Coverage Reform
The Chronic Care Policy Alliance (CCPA) recently submitted comments to the Senate Finance Committee Minority Staff in response to its…
Read MoreSeptember 23, 2026
Statement: Chronic Care Policy Alliance Commends Illinois Governor for Sharing His Experience as a Patient
Chronic Care Policy Alliance Commends Illinois Governor for Sharing His Experience as a Patient (SACRAMENTO, CA) — Today, Liz Helms,…
Read MoreSeptember 1, 2026
CCPA Submits Comments to Senate HELP Committee Chairman Cassidy on 340B Reform Discussion Draft
The Chronic Care Policy Alliance (CCPA) recently submitted comments to Senate HELP Committee Chairman Bill Cassidy on the discussion draft…
Read MoreAugust 14, 2026
Webinar Recap | Care Interrupted: How Insurance Barriers Impact Patients
Missed the webinar or want to share it with a colleague, caregiver, or advocate? Watch the full recording here. On…
Read MoreAugust 11, 2026
New HRSA Model Will Increase Transparency in 340B Program
CCPA has long advocated for thoughtful reforms to strengthen the 340B Drug Pricing Program. Earlier this year, CCPA submitted comments…
Read MoreAugust 6, 2026
Helping Patients Navigate Direct-to-Patient Prescription Platforms
For patients living with chronic and rare conditions, consistent access to prescription medicines is not optional. It is critical to…
Read MoreAugust 4, 2026
National Survey Finds Overwhelming Voter Support for Increasing Access to Obesity Medicines
(SACRAMENTO, CA) – The Chronic Care Policy Alliance (CCPA) announced today that a recent national survey showed strong, bipartisan support for increasing access to FDA-approved obesity medicines. Commissioned by CCPA, the Morning Consult survey of 2,001 registered voters nationwide also found…
Read MoreJuly 9, 2026
CCPA Submits Comments to FDA on Peptide Compounding
CCPA Submits Comments to FDA on Peptide Compounding The Chronic Care Policy Alliance (CCPA) submitted comments to the FDA’s Pharmacy…
Read MoreJune 16, 2026
CCPA Submits Comment Letter to CMS on Proposed Interoperability Standards and Prior Authorization for Drugs rule
On June 15, 2026, Chronic Care Policy Alliance (CCPA) submitted comments to the Centers for Medicare & Medicaid Services (CMS)…
Read MoreJune 9, 2026
Denied — but Not Defeated: Appeals Help Patients Access Care
Many patients know the sinking feeling when they learn a prescription, a specialist visit, a diagnostic test, or an ongoing…
Read MoreJune 8, 2026
Energy, Insight, and Inspiration: Inside Forecast 2026
Forecast 2026 brought together advocates, health policy experts, health care professionals, and community partners from across the country in San…
Read MoreMay 15, 2026
CCPA Sends Comments to Congress on the Dangers of MFN Pricing Models
The Chronic Care Policy Alliance (CCPA) recently submitted letters to Senate leadership, the Senate HELP and Finance Committees, as well…
Read MoreApril 22, 2026
CCPA Statement on Most Favored Nation
Liz Helms, CEO of the Chronic Care Policy Alliance (CCPA), issued the following statement on Most Favored Nation pricing: “Most Favored Nation…
Read MoreApril 20, 2026
Webinar Recap: Drug Pricing Reform: What Patients Need to Know
On April 9, 2026, CCPA hosted “Drug Pricing Reform: What Patients Need to Know,” a webinar moderated by CCPA CEO…
Read MoreApril 2, 2026
The Mass Compounded GLP-1 Market Is Harming Patients.
For people living with the chronic disease of obesity, GLP-1 medications have been life-changing. Research shows that sustained use reduces…
Read More